148 related articles for article (PubMed ID: 10099998)
21. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
[TBL] [Abstract][Full Text] [Related]
22. Postmenopausal endometrial hyperplasia: role of danazol therapy.
Mariani L; Sedati A; Giovinazzi R; Sindico R; Atlante G
Int J Gynaecol Obstet; 1994 Feb; 44(2):155-9. PubMed ID: 7911101
[TBL] [Abstract][Full Text] [Related]
23. [The effect of danazol and tamoxifen on endometrial hyperplasia].
Soh E
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
[TBL] [Abstract][Full Text] [Related]
24. Treatment of endometrial hyperplasia with a danazol-releasing intrauterine device: a prospective study.
Tamaoka Y; Orikasa H; Sumi Y; Sakakura K; Kamei K; Nagatani M; Ezawa S
Gynecol Obstet Invest; 2004; 58(1):42-8. PubMed ID: 15087596
[TBL] [Abstract][Full Text] [Related]
25. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
26. Endometrial hyperplasia with secretory changes.
Tresserra F; Lopez-Yarto M; Grases PJ; Ubeda A; Pascual MA; Labastida R
Gynecol Oncol; 2003 Mar; 88(3):386-93. PubMed ID: 12648591
[TBL] [Abstract][Full Text] [Related]
27. D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study.
Porcaro G; Bilotta G; Capoccia E; Bezerra Espinola MS; Aragona C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373229
[TBL] [Abstract][Full Text] [Related]
28. The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group.
Terakawa N; Kigawa J; Taketani Y; Yoshikawa H; Yajima A; Noda K; Okada H; Kato J; Yakushiji M; Tanizawa O; Fujimoto S; Nozawa S; Takahashi T; Hasumi K; Furuhashi N; Aono T; Sakamoto A; Furusato M
J Obstet Gynaecol Res; 1997 Jun; 23(3):223-30. PubMed ID: 9255033
[TBL] [Abstract][Full Text] [Related]
29. Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women.
Soh E; Sato K
Cancer; 1990 Sep; 66(5):983-8. PubMed ID: 2386926
[TBL] [Abstract][Full Text] [Related]
30. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
31. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
32. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
34. Letrozole as primary therapy for endometrial hyperplasia in young women.
Li HZ; Chen XN; Qiao J
Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
[TBL] [Abstract][Full Text] [Related]
35. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
[TBL] [Abstract][Full Text] [Related]
36. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
Ivanov S; Kovachev E; Tsonev A; Abbud A
Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
[TBL] [Abstract][Full Text] [Related]
37. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
39. Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?
Daggez M; Dolanbay M; Akgun H; Gülseren V; Keklikcioglu SA; Ozcelik B; Serin IS
Int J Gynecol Cancer; 2023 May; 33(5):707-712. PubMed ID: 37001896
[TBL] [Abstract][Full Text] [Related]
40. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
